{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-212084","form_type":"8-K","ticker":"ARAY","cik":"0001138723","company_name":"ACCURAY INC","filed_at":"2024-09-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.269742+00:00","generated_at":"2026-05-31T06:34:08.706691+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Accuray CEO Suzanne Winter takes temporary medical leave; Sandeep Chalke named interim CEO","bullets":["CEO Suzanne Winter taking temporary medical leave to treat a treatable form of cancer, effective September 3, 2024.","Sandeep Chalke, Chief Commercial Officer, appointed interim CEO; compensation raised to $725k base salary and 100% bonus target.","Board forms Executive Committee (Joseph Whitters and Anne Le Grand) to advise interim CEO during leave.","Winter: 'I go into my treatment program extremely knowledgeable and able to advocate for the care I need.'"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-212084","json":"https://secwatch.observer/filing/0001193125-24-212084.json","markdown":"https://secwatch.observer/filing/0001193125-24-212084.md","text":"https://secwatch.observer/filing/0001193125-24-212084.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1138723/000119312524212084/0001193125-24-212084-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1138723/000119312524212084/d822972d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T06:34:08.706691+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"212679b2d8","claim":"Suzanne Winter departed as President and Chief Executive Officer at ACCURAY INC.","evidence_excerpt":"On August 28, 2024, Suzanne Winter, President and Chief Executive Officer of Accuray Incorporated (the “Company”) informed the board of directors of the Company (the “Board”) that she is taking a temporary medical leave of absence, effective September 3, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1138723/000119312524212084/0001193125-24-212084-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"taken temporary medical leave of absence"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"43cbdfb82f","claim":"Sandeep Chalke was appointed as interim Chief Executive Officer at ACCURAY INC.","evidence_excerpt":"On August 30, 2024, in connection with Ms. Winter’s leave of absence and effective September 3, 2024, the Board appointed Sandeep Chalke, the Company’s Chief Commercial Officer, as the Company’s interim Chief Executive Officer and interim principal executive officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1138723/000119312524212084/0001193125-24-212084-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"interim Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}